Stifel Financial’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Stifel Financial’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-16,562	Closed	-$716K	–	2454
2015 Q3	$716K	Sell	16,562 -778	-4%	-$32.8K	﹤0.01%	1364
2015 Q2	$733K	Sell	17,340 -262	-1%	-$11K	﹤0.01%	1491
2015 Q1	$683K	Buy	17,602 +4,557	+35%	+$176K	﹤0.01%	1462
2014 Q4	$439K	Sell	13,045 -6,228	-32%	-$220K	﹤0.01%	1679
2014 Q3	$675K	Sell	19,273 -781	-4%	-$26.8K	0.01%	1352
2014 Q2	$659K	Sell	20,054 -581	-3%	-$19.9K	0.01%	1332
2014 Q1	$761K	Buy	+20,635	New	+$757K	0.01%	1201

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Stifel Financial's WX Position: Q4 2015 in Review

Stifel Financial sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 16,562 shares — an estimated $716K sold.

Stifel Financial first reported a position in WX in Q1 2014 and held it in 7 quarters. The position peaked at $761K in Q1 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Stifel Financial reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Stifel Financial sold 16,562 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $716K.
Stifel Financial first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 7 quarters.
Stifel Financial's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $761K in Q1 2014.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Stifel Financial's 13F filing for Q4 2015, filed 16 Feb 2016.